Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Osteaoarticular infection due to C. acnes are known to be of late onset, causing chronic infection possibly pauci-symptomatic. Osteaoarticular infection due to C. acnes represents a diagnostic challenge, since C. acnes is slow and difficult to grow, and can also be considered a contaminant.A 16S universal PCR bacteriological diagnosis has been proposed but is lacking of sensitivity. A specific C. acnes PCR was developed in 2010, but is not used routinely.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Prosthetic joint infection with Cutibacterium acnes | Chronic infections on articular prostheses with Cutibacterium acnes diagnosed by specific PCR |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Prosthetic joint infection with Cutibacterium acnes | Other | patients having a prosthesis infection with C.acnes identified by specific PCR |
|
| Measure | Description | Time Frame |
|---|---|---|
| Rate of diagnostic delay | time between surgery and detection of C. acnes by PCR | Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption |
| Measure | Description | Time Frame |
|---|---|---|
| rate of radiologic signs | prosthesis loosening or not | Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption |
| rate of duration of antibiotherapy |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
patients having had infection prothesis vith C. acnes identified by PCR and managed at the croix rousse hospital
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Tristan Ferry, Md,PhD | HCL | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospices Civils de Lyon | Lyon | 69004 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| C067540 | chloropentaamminerhodium(III) |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
measures of duration of the antibiotherapy
| Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption |
| rate of use of this diagnostic | descriptions of patients managed with this diagnostic | Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption |